These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11388569)
1. Adsorption of radiopharmaceuticals to syringes leads to lower administered activity than intended. Gunasekera RD; Notghi A; Mostafa AB; Harding LK Nucl Med Commun; 2001 May; 22(5):493-7. PubMed ID: 11388569 [TBL] [Abstract][Full Text] [Related]
2. Adsorption of some technetium-99m radiopharmaceuticals onto disposable plastic syringes. Jansson BA; Göransson MB; Agren BN J Nucl Med Technol; 1998 Sep; 26(3):196-9. PubMed ID: 9755440 [TBL] [Abstract][Full Text] [Related]
3. Systematic Assessment of the Adsorption of Kvaternik H; Gatterer J; Plhak E; Schwarzgruber JF; Aigner RM J Nucl Med Technol; 2020 Jun; 48(2):168-173. PubMed ID: 31811065 [TBL] [Abstract][Full Text] [Related]
4. Adsorption of (99m)Tc-radiopharmaceuticals onto injection vials and syringes. Mushtaq A; Ur Rehman T; Safdar Mansur M; Jehangir M J Nucl Med Technol; 2008 Jun; 36(2):91-4. PubMed ID: 18483140 [TBL] [Abstract][Full Text] [Related]
5. Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringes. Bartosch R; Granegger S; Sinzinger H Eur J Nucl Med; 1998 Sep; 25(9):1333-5. PubMed ID: 9724385 [TBL] [Abstract][Full Text] [Related]
6. In vitro adsorption of 99Tc(m)-MIBI, 99Tc(m)-tetrofosmin, 99Tc(m)-furifosmin and 99Tc(m)O4- onto tubes. Rodrigues M; Chehne F; Sinzinger H Nucl Med Commun; 2001 Jan; 22(1):105-10. PubMed ID: 11233544 [TBL] [Abstract][Full Text] [Related]
7. [Impact of Residual Radioactivity Rate of Nakamura Y; Kangai Y; Sato S; Shibata S; Abe T; Mimura H; Inubushi M Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Aug; 79(8):802-809. PubMed ID: 37357400 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes. Koslowsky IL; Brake SE; Bitner SJ J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532 [TBL] [Abstract][Full Text] [Related]
9. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals. Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414 [TBL] [Abstract][Full Text] [Related]
10. Preparation of 99mTc-MAG3: radiochemical purity is affected by the residence time of sodium chloride injection in a three-part syringe. Waight CC; Beattie LA; O'Brien LM; Millar AM Nucl Med Commun; 2006 Feb; 27(2):197-200. PubMed ID: 16404235 [TBL] [Abstract][Full Text] [Related]
11. Impact of disposable syringes type choice on myocardial perfusion imaging procedures with [ Ladriere T; Desmonts C; Zimmermann PA; Peyronnet D; Agostini D; Vigne J J Nucl Cardiol; 2023 Aug; 30(4):1399-1405. PubMed ID: 36352084 [TBL] [Abstract][Full Text] [Related]
12. Assessment of 99mTc-succimer residual activity using inert nonreactive syringes. Galbraith W; Chen X; Talley K; Grantham V J Nucl Med Technol; 2015 Mar; 43(1):61-3. PubMed ID: 25537761 [TBL] [Abstract][Full Text] [Related]
13. Retention of 99mTc-DMSA(III) and 99mTc-nanocolloid in different syringes affects imaging quality. Bauwens M; Pooters I; van der Pol J; Mottaghy FM; van Kroonenburgh M Nucl Med Commun; 2014 Apr; 35(4):433-7. PubMed ID: 24569706 [TBL] [Abstract][Full Text] [Related]
14. A rapid and stable ITLC procedure for the determination of the radiochemical purity of 99Tcm-tetrofosmin. van Hemert FJ; Schimmel KJ; van Eck-Smit BL Nucl Med Commun; 2001 Jun; 22(6):641-4. PubMed ID: 11403174 [TBL] [Abstract][Full Text] [Related]
15. Feasibility study of radioactivity estimation of Nakamura Y; Yasuno N Radiol Phys Technol; 2024 Jun; 17(2):396-401. PubMed ID: 38517669 [TBL] [Abstract][Full Text] [Related]
16. Adsorption of radiopharmaceuticals to syringes: setting up a reliable protocol for its assessment. Stopar TG; Socan A; Peitl PK Nucl Med Commun; 2007 Dec; 28(12):951-5. PubMed ID: 18090223 [TBL] [Abstract][Full Text] [Related]
17. Adsorption of 99mTc-sestamibi onto plastic syringes: evaluation of factors affecting the degree of adsorption and their impact on clinical studies. Swanson TN; Troung DT; Paulsen A; Hruska CB; O'Connor MK J Nucl Med Technol; 2013 Dec; 41(4):247-52. PubMed ID: 24212450 [TBL] [Abstract][Full Text] [Related]
18. Miniaturized Radiochemical Purity Testing for Fuente A; Zanca R; Boni R; Cataldi AG; Sollini M; Lazzeri E; Mariani G; Erba PA J Nucl Med Technol; 2017 Sep; 45(3):236-240. PubMed ID: 28705928 [TBL] [Abstract][Full Text] [Related]
19. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans. Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309 [TBL] [Abstract][Full Text] [Related]
20. Trapping of technetium-99m albumin macroaggregate and other four radiopharmaceuticals by blood clots in vitro. Zanglis A; Andreopoulos D; Baziotis N Hell J Nucl Med; 2007; 10(1):24-5. PubMed ID: 17450246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]